SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-07-041361
Filing Date
2007-02-28
Accepted
2007-02-27 20:20:13
Documents
8
Period of Report
2006-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1218385
2 SUBSIDIARIES OF BIOMARIN PHARMACEUTICAL INC. dex211.htm EX-21.1 2746
3 CONSENT OF KPMG LLP, INDEPENDENT PUBLIC ACCOUNTING FIRM dex231.htm EX-23.1 3045
4 CONSENT OF PRICEWATERHOUSECOOPERS, LLP, INDEPENDENT PUBLIC ACCOUNTING FIRM dex232.htm EX-23.2 1740
5 CERTIFICATION OF CHIEF EXECUTIVE OFFICER dex311.htm EX-31.1 7513
6 CERTIFICATION OF CHIEF FINANCIAL OFFICER dex312.htm EX-31.2 7581
7 CERTIFICATION OF CHIEF EXECUTIVE OFFICER AND CHIEF FINANCIAL OFFICER dex321.htm EX-32.1 3274
8 BIOMARIN/GENZYME LLC CONSOLIDATED FINANCIAL STATEMENTS dex991.htm EX-99.1 172485
  Complete submission text file 0001193125-07-041361.txt   1418147
Mailing Address 105 DIGITAL DRIVE NOVATO CA 94949
Business Address 105 DIGITAL DRIVE NOVATO CA 94949 4155066700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 07654939
SIC: 2834 Pharmaceutical Preparations